A team of researchers from the Faculty of Medicine, Nursing and Health Sciences (MNHS) Department of Infectious Diseases, the Faculty of Information Technology (IT) and The Alfred's Department of Infectious Diseases have been awarded $3.4M from the Medical Research Future Fund (MRFF) for the SuperbugAi Flagship project. With the focus on superbugs during World Antimicrobial Resistance Awareness Week (November 18-24), the innovative project will integrate genomics, electronic healthcare data and artificial intelligence (AI) technologies to address antimicrobial resistance in the healthcare system. The research, which will be mainly based at The Alfred, will also create a tracking and response system which will lead to earlier detection of superbugs, personalised treatment for patients and prevention of outbreaks. SuberbugAi has the potential to save patient lives, prevent superbug spread, and improve healthcare quality, resource use and costs. Lead researcher, Professor Anton Peleg is one of The Alfred's leading physician-scientists and is internationally recognised for his work in antimicrobial resistance.